MRNA stock · SKYX stock

MRNA vs SKYX · rev $145.0M vs rev $47.4M

Moderna Inc (MRNA) versus SKYX Platforms Corp (SKYX) — a side-by-side from cached financials, not a winner call.

Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..

SKYX Platforms Corp (SKYX) is a electrical equipment & parts company listed on US.

Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.

Latest reported SKYX revenue for 2026-06-30 was $47.4M. Net income was -$17.5M. SKYX currently screens at market cap $119.7M.

MRNA currently screens at market cap $24.52B. SKYX currently screens at market cap $119.7M.

Not investment advice. Open the MRNA and SKYX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons